glp 1 agonists tirzepatide Bridging the gap between GLP1-receptor and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Decoding GLP-1 Weight Loss Medications

Your body literally burns fewer calories doing the exact same activities

If retained gastric contents are identified, the management pathways include (1) postponing the procedure, (2) proceeding with the procedure with precautions taken to prevent aspiration (eg, endotracheal intubation), or (3) accelerating gastric emptying pharmacologically

Rosenbaum, M., and Leibel, R

These key players are accelerating the trend of innovation in obesity therapeutics with the creation of GLP-1 receptor agonists, dual and triple agonists, oral medications and new biologics with massive intellectual property holdings, strong clinical pipeline, and high-quality manufacturing and distribution

This is not to bash them, but to keep from putting them on an impossible pedestal that is bound to disappoint